Daily Ards Research Analysis
A multicentre prospective study in Thorax evaluated the generalisability of ARDS biological subphenotype models in Asian patients and found poor intermodel agreement despite similar subgroup distributions, underscoring the need for model harmonisation before bedside use. A mechanistic study identified macrophage-derived exosomal BMPR2 as a paracrine driver of alveolar epithelial repair via the BMPR1B–SMAD1–ID1 axis. A Chinese case-control study linked elevated cytokines and specific TLR/IL polym
Summary
A multicentre prospective study in Thorax evaluated the generalisability of ARDS biological subphenotype models in Asian patients and found poor intermodel agreement despite similar subgroup distributions, underscoring the need for model harmonisation before bedside use. A mechanistic study identified macrophage-derived exosomal BMPR2 as a paracrine driver of alveolar epithelial repair via the BMPR1B–SMAD1–ID1 axis. A Chinese case-control study linked elevated cytokines and specific TLR/IL polymorphisms to ARDS susceptibility, highlighting candidate biomarkers for risk stratification.
Research Themes
- Biological subphenotypes and precision medicine in ARDS
- Macrophage exosomes driving epithelial repair mechanisms
- Inflammatory biomarkers and host genetics in ARDS susceptibility
Selected Articles
1. Generalisability of ARDS biological subphenotype models in Asians: an international, multicentre, prospective biomarker study.
In a prospective multicentre cohort of 356 ARDS patients from Beijing and Pittsburgh, six established biological subphenotype classifiers predicted similar hyper- vs hypoinflammatory proportions in Asians, but intermodel agreement was poor. Asian patients meeting the Berlin Definition exhibited higher inflammatory profiles than HFNC-ARDS, underscoring heterogeneity by definition and the need to harmonise models before bedside deployment.
Impact: This study provides the first prospective, international assessment of ARDS subphenotype model generalisability in Asians and identifies critical model discordance that could undermine precision-medicine deployment.
Clinical Implications: Clinicians should exercise caution when applying existing ARDS subphenotype classifiers to Asian patients; model harmonisation and external validation are prerequisites for selecting patients for subphenotype-targeted therapies.
Key Findings
- Similar predicted proportions of hyperinflammatory vs hypoinflammatory subphenotypes in Asian and Caucasian cohorts across models
- Poor intermodel agreement among six established classifiers in Asian ARDS
- Higher inflammatory biomarker profiles in Berlin-defined ARDS compared with HFNC-ARDS within the Asian cohort
- Prospective enrolment of 356 ARDS patients with 37 biomarkers measured in Beijing and 10 overlapping in Pittsburgh
Methodological Strengths
- Prospective, international, multicentre design with predefined biomarker panels
- Sensitivity analyses including latent class analysis and trial registration (NCT02975908)
Limitations
- Poor intermodel agreement limits immediate clinical translation
- Only 10 overlapping biomarkers across cohorts may constrain cross-cohort comparability
- Observational design without interventional validation
Future Directions: Harmonise classifier inputs and thresholds across cohorts, prospectively test predictive utility for therapy response, and expand biomarker panels with multi-omics for improved calibration in diverse populations.
PURPOSE: Subphenotype classifiers for acute respiratory distress syndrome (ARDS) dichotomise patients into hyperinflammatory versus hypoinflammatory subgroups. These models demonstrated prognostic and predictive values but were developed primarily in Caucasian populations. Generalisability of these models in Asian patients, who experience worse clinical outcomes, has not been established. We aimed to profile host responses in Asian patients with ARDS and evaluate the generalisability of established classifiers in this understudied population compared with a Caucasian cohort. METHODS: We prospectively enrolled patients with ARDS from medical intensive care units in Beijing, China, and Pittsburgh, Pennsylvania, USA. In the Beijing cohort, 37 protein biomarkers were measured, with 10 overlapping biomarkers measured in the Pittsburgh cohort. Six established subphenotype models were assessed for generalisability and intermodel agreement. Sensitivity analyses, including latent class analysis, were conducted to explore biological heterogeneity within Asians. RESULTS: Between 2011 and 2020, a total of 356 patients with ARDS (83% meeting the Berlin Definition; the rest on high-flow nasal cannula (HFNC) meeting the New Global Definition) were enrolled across Beijing (97% Han Asian) and Pittsburgh (90% Caucasian) sites, with comparable baseline hypoxaemia severity but disparate outcome. While the proportion of hyperinflammatory versus hypoinflammatory subphenotypes was predicted to be overall similar across different cohorts per each model, we observed poor intermodel agreement. We observed heightened inflammation in Berlin patients with ARDS compared with HFNC-ARDS within our Asian cohort. CONCLUSION: Established subphenotype classifiers demonstrated similar distribution of subphenotypes in Asian patients with ARDS. However, poor intermodel agreement highlights the need for further investigation into model variability with models coming closer to bedside implementation. TRIAL REGISTRATION NUMBER: NCT02975908.
2. Macrophage-Derived Exosomal BMPR2 Mediates Alveolar Epithelial Repair and Cellular Crosstalk in Acute Lung Injury.
Macrophage-derived exosomes enhanced alveolar epithelial repair after blast injury, with proteomics implicating exosomal BMPR2 as a key effector that activates BMPR1B–SMAD1–ID1 signaling to drive AT2-to-AT1 transdifferentiation. These findings reveal a previously unrecognized paracrine mechanism and suggest BMPR2 signaling as a therapeutic target in ALI/ARDS.
Impact: It uncovers a novel exosome-mediated BMPR2 signaling mechanism for epithelial repair, offering a mechanistically grounded target with translational potential.
Clinical Implications: While preclinical, targeting BMPR2-mediated exosomal signaling could inspire therapies to enhance alveolar repair in ALI/ARDS; validation in in vivo models and human tissues is needed before clinical translation.
Key Findings
- Macrophage-derived exosomes (169.7 ± 61.6 nm) increased epithelial viability, reduced apoptosis, and promoted proliferation after blast injury
- Proteomics identified BMPR2 as a predominant effector (LG score 5.182) with stable BMPR2–BMPR1B interaction by molecular docking
- Exosomes promoted AT2-to-AT1 transdifferentiation via activation of the TGF-β BMPR1B–SMAD1–ID1 pathway
Methodological Strengths
- Multipronged mechanistic approach including proteomics, CETSA, immunofluorescence, and molecular docking
- Defined in vitro blast injury model with macrophage–epithelial coculture to assess functional repair
Limitations
- Findings are limited to in vitro systems without in vivo validation
- Use of murine cell lines (J774A.1, MLE-12) may limit human translatability
- Molecular docking predictions require orthogonal confirmation
Future Directions: Validate BMPR2 exosomal signaling in vivo and in human ARDS tissues, define dose–response and safety of exosome-based interventions, and map upstream regulators to enable druggable entry points.
BACKGROUND: Acute lung injury (ALI)/Acute respiratory distress syndrome (ARDS) continues to be a predominant cause of morbidity and mortality among critically ill patients, with few therapeutic options available. Although macrophage-derived exosomes have been identified as significant mediators of intercellular communication in tissue repair, their specific molecular mechanisms in the context of ALI remain inadequately understood. This study aims to investigate the role of macrophage-derived exosomes containing bone morphogenetic protein receptor 2 (BMPR2) in promoting the repair of blast-induced acute lung injury. METHODS: We established an in vitro blast injury model utilizing MLE-12 alveolar epithelial cells and isolated exosomes from J774A.1 macrophages through ultracentrifugation. Coculture experiments were conducted to evaluate cellular repair mechanisms, while molecular docking simulations were employed to predict protein interactions. We utilized cellular thermal shift assay (CETSA) analysis, Western blotting, and immunofluorescence to characterize the effects of exosomes on epithelial cell function and signaling pathways. RESULTS: Macrophage-derived exosomes, with a diameter of 169.7 ± 61.6 nm, significantly enhanced the viability of alveolar epithelial cells, reduced apoptosis, and promoted proliferation following blast injury. Proteomic analysis identified BMPR2 as the predominant effector protein, with an LG score of 5.182. Molecular docking studies revealed stable binding interactions between BMPR2 and BMPR1B. Functionally, exosomes facilitated the transdifferentiation of alveolar type II (AT2) cells to type I (AT1) cells through the activation of the TGF-β signaling pathway via the BMPR1B-SMAD1-ID1 axis, thereby promoting epithelial repair and regeneration. CONCLUSION: This study establishes that exosomal BMPR2 derived from macrophages serves as a previously unrecognized paracrine signaling mechanism facilitating cellular crosstalk during ALI repair. The BMPR2-mediated signaling pathway offers a promising therapeutic target for the treatment of ALI, paving the way for new avenues in clinical intervention.
3. The significance and role of the receptor and inflammatory factors in acute respiratory distress syndrome.
In a Chinese case-control study (240 ARDS vs 420 controls), ARDS was associated with elevated serum cytokines and specific TLR/IL polymorphisms, with IL-1 and TNF-α elevations and TLR2 deletion, TLR9 rs352140, and IL-1B +3954 remaining significant after FDR correction. Results were consistent across ARDS etiologies, supporting candidate biomarkers for susceptibility stratification.
Impact: It rigorously links inflammatory profiles and host genetics to ARDS susceptibility in an underrepresented population, using FDR control and adjusted models.
Clinical Implications: These markers could inform risk stratification in high-risk settings and guide future prognostic models, though they are not ready for routine screening without external validation.
Key Findings
- ARDS patients had higher serum levels of IL-1 and TNF-α after FDR correction; several other cytokines were elevated before correction
- Genetic variants associated with ARDS susceptibility included TLR2 −196 to −174 del, TLR9 rs352140 AA, and IL-1B +3954 TT, remaining significant after FDR
- Associations were robust across ARDS etiologies in sensitivity analyses
Methodological Strengths
- Adequate sample size with age- and sex-matched controls and multivariable adjustment
- Multiplicity control via Benjamini–Hochberg FDR and sensitivity analyses by etiology
Limitations
- Case-control design limits causal inference and may be subject to residual confounding
- Single-timepoint cytokine measurements and hospital-based sampling may affect generalisability
- Findings limited to a Chinese population; external validation needed
Future Directions: Validate these biomarkers and SNP associations in multicentre, multiethnic cohorts; assess prognostic value and integration into clinical risk scores; explore functional genomics of implicated variants.
Acute respiratory distress syndrome (ARDS) is a life-threatening condition characterized by diffuse alveolar damage and severe hypoxemia, with mortality rates remaining high despite advances in supportive care. Cytokine dysregulation and genetic susceptibility are thought to play central roles in its pathogenesis, but data in Chinese populations remain limited. This study aimed to investigate the associations of circulating cytokine levels and genetic polymorphisms with ARDS risk. We enrolled 240 patients with ARDS and 420 age- and sex-matched healthy controls. Serum concentrations of TLR2, TLR4, TLR9, IL-1, IL-6, IL-8, IL-10, IL-17, TNF-α, and IFN-γ were quantified by ELISA. Selected single-nucleotide polymorphisms (SNPs) in TLR and cytokine genes were genotyped using PCR-RFLP with rigorous quality control, including Hardy-Weinberg equilibrium checks. Associations with ARDS risk were estimated using multivariable logistic regression adjusted for age, sex, BMI, smoking, diabetes, and hypertension. Multiplicity was addressed with the Benjamini-Hochberg false discovery rate (FDR). ARDS patients exhibited significantly elevated serum concentrations of TLR2, TLR4, TLR9, IL-1, IL-8, IL-10, IL-17, and TNF-α compared with controls (all p < 0.05), with IL-1 and TNF-α remaining significant after FDR correction. Several genetic variants were strongly associated with ARDS susceptibility, including TLR2 - 196 to - 174 del (OR = 1.85; 95% CI, 1.23-2.77), TLR9 rs352140 AA (OR = 2.97; 95% CI, 2.16-4.08), IL-1B + 3954 TT (OR = 5.01; 95% CI, 2.85-8.81), IL-10 - 1082 GA/AA, TNF-α - 308 AA, and IFN-γ + 874 TT. After FDR control, significant associations persisted for TLR2 - 196 to - 174 del, TLR9 rs352140, and IL-1B + 3954. Sensitivity analyses stratified by ARDS etiology (pneumonia, sepsis, trauma, other) yielded consistent results. Both inflammatory dysregulation and host genetic variation contribute to ARDS susceptibility in Chinese patients. Elevated cytokines (IL-1, TNF-α, IL-10) and specific polymorphisms (TLR2 - 196 to - 174 del, TLR9 rs352140, IL-1B + 3954) may serve as candidate biomarkers for risk stratification. These findings warrant validation in larger multicenter cohorts and exploration of their prognostic value in clinical practice.